Percutaneous ultrasound-guided laser ablation for the treatment of cervical tuberculous lymphadenitis: a pilot study
Title: | Percutaneous ultrasound-guided laser ablation for the treatment of cervical tuberculous lymphadenitis: a pilot study |
---|---|
Authors: | Gaoyi Yang, Jianhua Fang, Tianzhuo Yu, Ying Zhang, Wenzhi Zhang, Dan Zhao, Jianping Xu, Caifen Wang |
Source: | Journal of International Medical Research, Vol 47 (2019) |
Publisher Information: | SAGE Publishing, 2019. |
Publication Year: | 2019 |
Collection: | LCC:Medicine (General) |
Subject Terms: | Medicine (General), R5-920 |
More Details: | Objective This study was performed to assess the feasibility, effectiveness, and safety of percutaneous ultrasound (US)-guided laser ablation (LA) for the treatment of cervical tuberculous lymphadenitis (CTBL). Methods We retrospectively reviewed 11 patients with CTBL (mean age, 32.0 ± 8.6 years; range, 18–47 years) who underwent percutaneous US-guided LA from June 2014 to December 2016 with a subsequent 12-month follow-up. We assessed the mean volume reduction and contrast-enhanced US (CEUS) changes of the target lymph nodes as well as the tolerability and adverse effects of LA. Results The mean ablation energy was 522 ± 312 J (range, 204–1317 J). All 17 enrolled target lymph nodes were completely non-enhanced after LA treatment as detected by CEUS, indicating complete ablation of all lymph nodes (100%). The target lymph nodes significantly decreased in volume by a mean of 74.0% ± 15.6% from baseline to 12 months after LA. The LA procedure was well tolerated, and none of the 11 patients developed severe complications during the 12-month follow-up. Conclusion Percutaneous US-guided LA for the treatment of CTBL exhibits good tolerability, minimal invasiveness, and few adverse effects. Further investigations with larger sample sizes and longer follow-up periods are warranted to confirm these findings. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 0300-0605 1473-2300 03000605 |
Relation: | https://doaj.org/toc/0300-0605; https://doaj.org/toc/1473-2300 |
DOI: | 10.1177/0300060518821818 |
Access URL: | https://doaj.org/article/216f3febe37f42f786d5fe9792b2d0f5 |
Accession Number: | edsdoj.216f3febe37f42f786d5fe9792b2d0f5 |
Database: | Directory of Open Access Journals |
ISSN: | 03000605 14732300 |
---|---|
DOI: | 10.1177/0300060518821818 |
Published in: | Journal of International Medical Research |
Language: | English |